SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Agenus Inc

Agenus is drawing attention after three-year follow-up data for BOT+BAL in recurrent ovarian cancer showed estimated overall survival holding at 48%. Bulls view the durability as encouraging, while cautious traders point to the small, uncontrolled Phase 1b study and the fact that the treatment remains investigational.

TRON is a decentralized blockchain-based operating system designed to accelerate the decentralization of the internet and its underlying infrastructure. It serves as a global settlement layer for stablecoins and everyday digital purchases, providing a high-throughput environment to support large-scale decentralized applications. The network is governed by a decentralized autonomous organization (DAO), which allows the community to manage the protocol without a central authority. Its primary value proposition includes a unique resource model that utilizes bandwidth and energy to allow for high transaction volumes without traditional fee spikes.  The platform functions as a smart contract platform that enables the creation of decentralized applications and is compatible with the Ethereum Virtual Machine, allowing developers to easily migrate applications. TRON operates using a Delegated Proof of Stake consensus mechanism where token holders vote for 27 Super Representatives to verify transactions and maintain the ledger. This structure is built for scalability and fast finality, aiming to handle more transactions per second than many established legacy blockchains. Users can interact with the ecosystem for various purposes, including decentralized finance (DeFi) through platforms like JustLend DAO and decentralized storage via the BitTorrent File System.  Value moves through the system via its native utility token, TRX, which facilitates transactions and grants users access to network resources. Holders can lock their TRX in a staking mechanism to gain TRON Power, which is used to vote on network rules and elect Super Representatives, earning rewards for securing the network. Established by the TRON Foundation and led by founder Justin Sun, the project has transitioned into a community-led DAO. The ecosystem is supported by strategic partnerships with major global entities, including Samsung, which integrated TRON into its blockchain keystore, as well as BitTorrent, Opera, and Swisscom Blockchain.

Tron

TRON is drawing attention for holding relatively steady while traders track a consolidation range and debate whether it can break higher or remains stalled. The conversation is largely technical and sentiment-driven, with no single confirmed catalyst dominating.

Mattel, Inc. engages in the ownership of children's and family entertainment franchises. It operates through the following segments: North America, International, and American Girl. The North America and International segments focus on marketing and selling toys and consumer products. The American Girl segment includes marketing, retailing, and publishing dedicated to its mission to help girls grow up with confidence and character. The company was founded by Elliot Handler, Ruth Handler, and Harold Matson in 1945 and is headquartered in El Segundo, CA.

Mattel, Inc.

Reported private takeover discussions between Authentic Brands Group and Mattel are driving attention, with traders weighing the potential acquisition premium against the uncertainty that talks may not lead to a deal. The chatter follows CEO Ynon Kreizs departure and has fueled both buyout optimism and skepticism about whether the reported interest is firm.

Midnight is a privacy-first blockchain that blends public verifiability with confidential data handling. You can use Midnight's selective disclosure and ZK proofs to build apps.

Midnight

Midnights mainnet launch and ecosystem developmentsincluding major validators and payment/financial partnershipsare drawing attention, alongside reports of exchange listings. Traders are weighing the added visibility and real-world-use potential against weak follow-through, token-sale pressure, and concerns about centralization.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

Bankrs expanding AI-agent infrastructure and integrations across Base, Robinhood Chain, and other ecosystems are driving attention, with holders emphasizing platform usage, fee generation, and potential token value capture. The bullish utility thesis is balanced by concern about price pullbacks, limited volume, and whether adoption will translate into sustained token demand.

the cat on Base  community-run home for $BASECAT

Basecat

BASECAT is drawing attention amid a sharp pullback after an earlier Coinbase-related surge, with traders debating whether persistent selling signals a pump-and-dump or whether reported whale accumulation and bid support could precede a reversal. Some are buying dips and pointing to holder concentration, while others remain bearish about the coins prospects.

The mission of the Worldcoin project is to build the world’s largest identity and financial network as a public utility, giving ownership to everyone. A key component of the Worldcoin project is the development of the foundational infrastructure that will be important for a world where AI plays an increasingly large role.  The Worldcoin system revolves around World ID, a privacy-preserving global identity network. World ID enables users to verify their humanness online while maintaining their privacy through zero-knowledge proofs.  Using World ID, individuals will be able to prove that they are a real, unique human to any platform that integrates with the protocol, including to web3 systems, social networking sites, and governmental programs. This will enable fair airdrops or token/NFT sales, provide protection against bots/sybil attacks on social media, and enable the fairer distribution of limited governmental resources. Furthermore, World ID can also enable global democratic processes and novel forms of governance (e.g., via quadratic voting), and it may eventually show a path to AI-funded UBI. The Worldcoin token (WLD), alongside World ID, will let users participate in governing the Worldcoin protocol.   To engage with the Worldcoin protocol, individuals must first download a first wallet app that supports the creation of a World ID. Users visit a physical imaging device called the Orb to get their World ID Orb-verified. Orbs are operated by a network of independent local businesses called Orb Operators. The Orb uses multispectral sensors to verify humanness and uniqueness to issue an Orb-verified World ID, with all images being promptly deleted on-device per default (absent explicit consent to Data Custody). All Orb-verified World IDs holders are entitled to claim recurring grants of free WLD tokens, subject to certain availability restrictions. The WLD token is designed as a utility token with governance properties.

Worldcoin

Worldcoins rally and breakout are drawing attention, with traders pointing to Eightco/ORBSs reported large WLD holdings and speculating that proof-of-humanity could gain value as AI bots spread. Bullish posts anticipate further momentum, while skeptics cite sharp volatility and question whether ETF and OpenAI-related hopes will translate into sustained demand.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cashs sharp, volatile swings and breakout attempts are driving attention; some traders link a prior rally to CME futures access and a Grayscale filing, while others focus on pullbacks and BCHs perceived weakness versus Bitcoin. The community is split between accumulation and further-upside hopes and concerns that the moves may fade.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JASMYs renewed price and volume momentum is drawing attention, with traders pointing to a reported burst of JasmyChain activity using JASMY for gas and ongoing Panasonic/AI ecosystem development. Bulls see signs of emerging utility, while skeptics question whether the activity will translate into meaningful adoption and cite exchange delistings as a risk.

Subsquid Network is an innovative decentralized data lake and query engine designed to offer developers performant and permissionless access to data, aiming to build a neutral and open internet rooted in Web3 principles. Secured by ZK proofs, the Subsquid network boasts a modular architecture that enables exceptional scalability and developer convenience optimized for blockchain indexing, dApp development, and analytics.  Subsquid is a response to unscalable and rigid monolithic indexing frameworks that had previously gained popularity and market traction among Web3 developers. Today, these frameworks are struggling to adapt in a rapidly evolving blockchain environment. Additionally, the network serves as a highly efficient and decentralized alternative to centralized infrastructure firms, including large RPC and API providers.

Discussion is focused on reports that Subsquid CEO Wanja Oberhof was charged with fraud tied to a former company, not SQD; traders are debating whether the allegations could affect Subsquids ownership, operations, or Rezolve AIs contractual options, while others say the case is unrelated to SQD. The broader conversation also includes bullish speculation about SQDs blockchain-data infrastructure and enterprise adoption, alongside concerns about the tokens decline and uncertain value capture.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate Hike

ABT, CORT, PGEN and BHC offer low-beta healthcare exposure as rate-hike fears and market volatility persist.

Consumer Confidence Falls Amid Ongoing Geopolitical Tensions: 4 Picks 

BHC, CDNA, DOLE and CHEF offer defensive exposure as consumer confidence falls amid inflation and geopolitical tensions.

Zacks Value Investor Highlights: FOXF, BHC and QNST

FOXF, BHC and QNST emerge as hidden-gem value stocks under $20, with low valuation metrics and notable earnings growth prospects.

Screening for Hidden Gem Stocks Under $20

Are you tired of stocks over $100 or $1000? These three stocks are values but trade under $20.

Best Value Stocks to Buy for September 22nd

BHC, OPHC and TRVG made it to the Zacks Rank #1 (Strong Buy) value stocks list on September 22nd, 2026.

4 Healthcare Stocks to Play Safe as Fed Gears Up for Rate Hike

AMGN, BHC, CDNA and CNC offer defensive healthcare plays as inflation climbs and the Fed readies for a possible rate hike.

Bausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA Markets

Bausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA Markets Bausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA Markets PR Newswire LAVAL, QC, Sept. 8, 2026 Collaboration expands access to science-led, microbiome-friendly skincare solutions in...

Bausch Health Announces Availability of Solta Medical's Fraxel FTX in Australia

Bausch Health Announces Availability of Solta Medical's Fraxel FTX in Australia Bausch Health Announces Availability of Solta Medical's Fraxel FTX in Australia PR Newswire LAVAL, QC, Sept. 1, 2026 The next generation in skin resurfacing technology is available to Australian health care...

Bausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship Winners

Bausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship Winners Bausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship Winners PR Newswire LAVAL, QC, Aug. 27, 2026 This year's Aspire Higher scholarships are awarded to six students who have been...

Can Bausch (BHC) Run Higher on Rising Earnings Estimates?

Bausch Health (BHC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.

Bausch Health Companies Inc

BHC Stock Plummets On Failed Liver Cirrhosis Trial: Retail Says ‘Lost Battle But Not The War’

Equity

Bearish Sentiment

Up more than 5%

Flat to up 5%

Flat to down 5%

Down more than 5%

What&#39;s your expected total return for the S&amp;P 500 ($SPY) in Q4? 

Drop your reasoning in the comments.

Stocktwits

What's your expected total return for the S&P 500 (

) in Q4? 

Drop your reasoning in the comments.

Stocktwits Polls

$BHC How is it that none of the big investors go and yell at management because it's bullshit they stole the company 5 years ago? How is it possible that no one is screaming bloody murder? 5 years of a failed spinoff. How is that possible? How can they steal a company like that? And not give a flying fuck

$BHC today is the Jewish day of atonement. So today I atone for my original sin, purchasing this stock years ago. The forever stain on my trading history!

Morgan

$BHC Safe to assume large investors - led by Jana - are working towards a Cooper/BLCO tie up.  BHC simply can't afford to go in to  
'27 with the uncertainties surrounding Xifaxin......

$BHC what causes this to go up 10 percent pre market and drop everyday I notice it happens a lot with this stock in particular for past years

Coolhat1

$BHC the only thing keeping my hopes up after all this time now is appio being on blco board and the timing of it being right after annual share holder meeting is very amazing. I have feeling something might happen sooner or later 💯💯

$BHC honestly is it possible for them to cook there books in any way especially after valeant  I know they might be watched more closely, but they seem to always beat earning for years now and always have double digit growth in salix and solta while rest is flat almost to modest . I just hope they aren’t doing that.

$BHC  $BLCO St. Jude the Apostle is the patron saint of lost causes and impossible situations. At this point I doubt that even he could help this mess.

89quattro

$BHC im the proud owner of more shares at $5.89.. didn't buy my full trading position because of its weakness, but ready to pull the trigger on more if it keeps dropping. This cycle for a year has been so predictable.

$BHC 2 news releases, the push to $8 started. MnM's doin theie game. Total inside manipulation. Love it

BHC Bausch Health Companies Inc